Effects of Neoadjuvant Chemotherapy on Early Postoperative Anxiety and Depression in Patients With Gastric Cancer: An Observational Study.
[AIM] Neoadjuvant chemotherapy (NACT) improves surgical outcomes in gastric cancer, yet its effect on early postoperative mental health remains unclear.
- p-value p = 0.016
- p-value p = 0.026
- 95% CI 0.94-24.33
- OR 2.00
- 연구 설계 cohort study
APA
Cao D, Yu R, et al. (2025). Effects of Neoadjuvant Chemotherapy on Early Postoperative Anxiety and Depression in Patients With Gastric Cancer: An Observational Study.. Annali italiani di chirurgia, 96(11), 1541-1551. https://doi.org/10.62713/aic.4344
MLA
Cao D, et al.. "Effects of Neoadjuvant Chemotherapy on Early Postoperative Anxiety and Depression in Patients With Gastric Cancer: An Observational Study.." Annali italiani di chirurgia, vol. 96, no. 11, 2025, pp. 1541-1551.
PMID
41243535
Abstract
[AIM] Neoadjuvant chemotherapy (NACT) improves surgical outcomes in gastric cancer, yet its effect on early postoperative mental health remains unclear. This study aims to investigate the association between NACT and postoperative anxiety and depression.
[METHODS] A single-center, retrospective cohort study included 201 gastric cancer patients who underwent surgical resection from October 2023 to May 2024, categorized by NACT receipt. Psychological evaluation in the early postoperative phase was conducted using the Hospital Anxiety and Depression Scale (HADS), and associations with NACT were assessed through logistic regression.
[RESULTS] Of the 201 patients, 57 (28.4%) received NACT. Postoperative assessments showed significantly higher rates of anxiety (78.95% vs. 61.11%, p = 0.016) and depression (56.14% vs. 38.89%, p = 0.026) in NACT recipients compared to non-NACT patients. After adjusting for confounders, NACT remained independently associated with an increased prevalence of anxiety (Odds Ratio [OR] = 2.25) and depression (OR = 2.00, both p < 0.05). Patients undergoing more than three NACT cycles exhibited increased anxiety (91.67% vs. 69.70%, p = 0.045) and depression (75.00% vs. 42.42%, p = 0.014), with higher mean HADS scores (both p < 0.05). These associations persisted in adjusted analyses for depression (OR, 4.07; 95% Confidence Interval [CI], 1.28-12.90; p = 0.017) and were marginal for anxiety (OR, 4.78; 95% CI, 0.94-24.33; p = 0.059). Patients with poor response (tumor regression grade [TRG] 2-3) also showed a trend toward increased anxiety risk (OR, 3.30; 95% CI, 0.83-13.12; p = 0.089).
[CONCLUSIONS] NACT is independently associated with increased anxiety and depression in the early postoperative period, especially if chemotherapy cycles are prolonged.
[METHODS] A single-center, retrospective cohort study included 201 gastric cancer patients who underwent surgical resection from October 2023 to May 2024, categorized by NACT receipt. Psychological evaluation in the early postoperative phase was conducted using the Hospital Anxiety and Depression Scale (HADS), and associations with NACT were assessed through logistic regression.
[RESULTS] Of the 201 patients, 57 (28.4%) received NACT. Postoperative assessments showed significantly higher rates of anxiety (78.95% vs. 61.11%, p = 0.016) and depression (56.14% vs. 38.89%, p = 0.026) in NACT recipients compared to non-NACT patients. After adjusting for confounders, NACT remained independently associated with an increased prevalence of anxiety (Odds Ratio [OR] = 2.25) and depression (OR = 2.00, both p < 0.05). Patients undergoing more than three NACT cycles exhibited increased anxiety (91.67% vs. 69.70%, p = 0.045) and depression (75.00% vs. 42.42%, p = 0.014), with higher mean HADS scores (both p < 0.05). These associations persisted in adjusted analyses for depression (OR, 4.07; 95% Confidence Interval [CI], 1.28-12.90; p = 0.017) and were marginal for anxiety (OR, 4.78; 95% CI, 0.94-24.33; p = 0.059). Patients with poor response (tumor regression grade [TRG] 2-3) also showed a trend toward increased anxiety risk (OR, 3.30; 95% CI, 0.83-13.12; p = 0.089).
[CONCLUSIONS] NACT is independently associated with increased anxiety and depression in the early postoperative period, especially if chemotherapy cycles are prolonged.
MeSH Terms
Humans; Stomach Neoplasms; Male; Female; Retrospective Studies; Neoadjuvant Therapy; Anxiety; Depression; Middle Aged; Aged; Chemotherapy, Adjuvant; Postoperative Complications
같은 제1저자의 인용 많은 논문 (5)
- ISGylation prevents autophagic degradation of STING and promotes antitumor immunity in lung cancer.
- Mutant KRAS Suppresses DNA Sensing by Remodeling Membrane Tension to Clear Extracellular Tumor DNA.
- Pteris wallichiana bioactives induce ferroptosis via the SLC7A11-GSH-GPX4 axis to directly suppress colorectal cancer.
- Association of Recurrence with a Tumor-informed Personalized ctDNA Detection Approach in Resectable Colorectal Cancer: Results of a Prospective Observational Study.
- Stress granule regulator-associated genes predict drug sensitivity, immune infiltration, and prognosis in patients with gastric cancer: Insights from bioinformatic and experimental approaches.